Sebastian Böhme, Jessica Paas, Zoe Konjer, Jonas Meyrer, Jonas Schreyögg
{"title":"[Patient steering from a health economics perspective: conditions for effective cost-sharing in a European comparison].","authors":"Sebastian Böhme, Jessica Paas, Zoe Konjer, Jonas Meyrer, Jonas Schreyögg","doi":"10.1007/s00103-026-04301-y","DOIUrl":null,"url":null,"abstract":"<p><p>Rising health expenditures and demographic change increasingly challenge the financing and steering of healthcare in Germany. Cost-sharing instruments are recurrently discussed as a means of reducing inappropriate utilisation, most recently in the context of a primary care gatekeeping system. This article analyses the institutional design and empirical evidence on financial steering instruments in four European health systems (Germany, the Netherlands, France, Denmark) and synthesises the findings from a health economics perspective. The effectiveness of copayments emerges as a function of three interrelated conditions: the type of service, the behavioural-economic design and the institutional architecture. Uniform copayments are regressive and disproportionately burden insured persons with low income. Based on the international evidence, a reintroduction of the previous German practice fee (Praxisgebühr) is not advisable. A more promising approach would design copayments as a targeted steering instrument at points where inappropriate utilisation is empirically identified, such as when patients inappropriately bypass a coordinated care pathway. This requires accounting for behavioural-economic effects and income-related differences. Configured in this way, copayments can contribute to improving patient steering without jeopardising access to standard care.</p>","PeriodicalId":9562,"journal":{"name":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","volume":" ","pages":"1136-1145"},"PeriodicalIF":1.6000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13623994/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00103-026-04301-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Rising health expenditures and demographic change increasingly challenge the financing and steering of healthcare in Germany. Cost-sharing instruments are recurrently discussed as a means of reducing inappropriate utilisation, most recently in the context of a primary care gatekeeping system. This article analyses the institutional design and empirical evidence on financial steering instruments in four European health systems (Germany, the Netherlands, France, Denmark) and synthesises the findings from a health economics perspective. The effectiveness of copayments emerges as a function of three interrelated conditions: the type of service, the behavioural-economic design and the institutional architecture. Uniform copayments are regressive and disproportionately burden insured persons with low income. Based on the international evidence, a reintroduction of the previous German practice fee (Praxisgebühr) is not advisable. A more promising approach would design copayments as a targeted steering instrument at points where inappropriate utilisation is empirically identified, such as when patients inappropriately bypass a coordinated care pathway. This requires accounting for behavioural-economic effects and income-related differences. Configured in this way, copayments can contribute to improving patient steering without jeopardising access to standard care.
期刊介绍:
Die Monatszeitschrift Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - umfasst alle Fragestellungen und Bereiche, mit denen sich das öffentliche Gesundheitswesen und die staatliche Gesundheitspolitik auseinandersetzen.
Ziel ist es, zum einen über wesentliche Entwicklungen in der biologisch-medizinischen Grundlagenforschung auf dem Laufenden zu halten und zum anderen über konkrete Maßnahmen zum Gesundheitsschutz, über Konzepte der Prävention, Risikoabwehr und Gesundheitsförderung zu informieren. Wichtige Themengebiete sind die Epidemiologie übertragbarer und nicht übertragbarer Krankheiten, der umweltbezogene Gesundheitsschutz sowie gesundheitsökonomische, medizinethische und -rechtliche Fragestellungen.